Cointime

Kyras Therapeutics

company

About

Kyras Therapeutics is a biotech company

  • 1 - 10

Highlights

Funding Rounds
1
Investors
1

Details

Last Funding Type
Series A
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Kyras Therapeutics is a biotech company. According to data from the National Cancer Institute, more than 30 percent of all human cancers are driven by mutations in RAS genes, including 95% of pancreatic, 45% of colorectal, and 35% of lung cancers, among many others.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
—
Kyras Therapeutics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Dec 11, 2015 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 11, 2015 Series A — 1 Versant Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Kyras Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series A
Cointime
เนื้อหา
บริษัท